Authors:
HIRAOAKA A
MASAOKA T
SHIBATA H
KASAI M
MORIYAMA Y
KATO S
KODERA Y
MATSUYAMA T
HIRABAYASHI N
KANAMARU A
DOHY H
SHIMOSAKA A
TAKAKU F
Citation: A. Hiraoaka et al., 5 YEARS FOLLOW-UP OF A RANDOMIZED PLACEBO-CONTROLLED STUDY WITH FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 874-874
